Battling the TB/HIV Epidemic through Community Action Through advocacy workshops and by coordinating and supporting activists' advocacy efforts, TAG and ICW work together to increase community understanding of TB/HIV coinfection and enhance research, treatment, and resources to combat the two…
Why Are They Resistant to AIDS? By Richard Jefferys Since the 1980s, it has been documented that chimpanzees infected with HIV in research studies typically control viral replication and remain asymptomatic. In only a few reported cases have infected chimpanzees…
Large-Scale Vaccine Trial Nixed By Richard Jefferys NIAID's announcement that it would not support the 2,400-person PAVE100 trial left open the possibility of an even smaller trial, solely evaluating the impact on postinfection viral load set point. A little over…
By Bob Huff Better drugs are urgently needed for most of the people in the world who still lack treatment for HIV. Yet physician contentment with current treatment options in Europe and the United States may hold back research to…
Hindsight versus Foresight By Richard Jefferys While still analyzing data from the third ever AIDS vaccine efficacy trial, the field is serenaded by a chorus of opinions. On March 25, the National Institute of Allergy and Infectious Diseases (NIAID) convened…
Not Nearly Enough By Bob Huff In the midst of a “golden age” of abundant antiretroviral treatments some worry that our “embarrasment of riches” will leave us wanting unless we continue the search for better drugs. TAG’s Antiretroviral (ARV) Pipeline…
By Bob Huff The Indian generic pharmaceutical industry, operating under Indian patent laws that permitted liberal copying of medicines, made possible the revolution in antiretroviral treatment access that has occurred in Africa since 2001. In April, 25 treatment activists from…
By Bob Huff Online webcasts make CROI (the Conference on Retroviruses and Opportunistic Infections) the most accessible major scientific meeting on AIDS. Webcasts are accessed through the main website at www.retroconference.org/2008. Click on View the Webcasts and Podcasts. The webcast…
Comments by Mark Harrington, executive director of Treatment Action Group, for the Ford Foundation–hosted meeting on developing a national AIDS strategy for the United States In April 2008, the Ford Foundation hosted a meeting of over 40 national AIDS leaders…
Hopes Dim for Struggling Field By Richard Jefferys Immunizations in a trial of Merck's HIV vaccine were stopped when it was determined that the vaccine was not working. There are now concerns that the vaccine may have increased the risk…